Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments
While few studies have revealed the biological properties of brassicasterol, a phytosterol, against some biological and molecular targets, it is believed that there are still many activities yet to be studied. In this work, brassicasterol exerts a therapeutic utility in an in vitro setting against h...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/8/5/132 |
| _version_ | 1827716340213874688 |
|---|---|
| author | Sherif T. S. Hassan |
| author_facet | Sherif T. S. Hassan |
| author_sort | Sherif T. S. Hassan |
| collection | DOAJ |
| description | While few studies have revealed the biological properties of brassicasterol, a phytosterol, against some biological and molecular targets, it is believed that there are still many activities yet to be studied. In this work, brassicasterol exerts a therapeutic utility in an in vitro setting against herpes simplex virus type 1 (HSV-1) and <i>Mycobacterium tuberculosis</i> (Mtb) as well as a considerable inhibitory property against human angiotensin-converting enzyme (ACE) that plays a dynamic role in regulating blood pressure. The antireplicative effect of brassicasterol against HSV-1 is remarkably detected (50% inhibitory concentration (IC<sub>50</sub>): 1.2 µM; selectivity index (SI): 41.7), while the potency of its effect is ameliorated through the combination with standard acyclovir with proper SI (IC<sub>50</sub>: 0.7 µM; SI: 71.4). Moreover, the capacity of this compound to induce an adequate level of antituberculosis activity against all Mtb strains examined (minimum inhibitory concentration values ranging from 1.9 to 2.4 µM) is revealed. The anti-ACE effect (12.3 µg/mL; 91.2% inhibition) is also ascertained. Molecular docking analyses propose that the mechanisms by which brassicasterol induces anti-HSV-1 and anti-Mtb might be related to inhibiting vital enzymes involved in HSV-1 replication and Mtb cell wall biosynthesis. In summary, the obtained results suggest that brassicasterol might be promising for future anti-HSV-1, antituberculosis, and anti-ACE drug design. |
| first_indexed | 2024-03-10T19:38:09Z |
| format | Article |
| id | doaj.art-e5243e048ceb4190a7ef32e03f2504b7 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-10T19:38:09Z |
| publishDate | 2020-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-e5243e048ceb4190a7ef32e03f2504b72023-11-20T01:34:56ZengMDPI AGBiomedicines2227-90592020-05-018513210.3390/biomedicines8050132Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico AssessmentsSherif T. S. Hassan0Department of Applied Ecology, Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Kamýcká 129, 6-Suchdol, 16521 Prague, Czech RepublicWhile few studies have revealed the biological properties of brassicasterol, a phytosterol, against some biological and molecular targets, it is believed that there are still many activities yet to be studied. In this work, brassicasterol exerts a therapeutic utility in an in vitro setting against herpes simplex virus type 1 (HSV-1) and <i>Mycobacterium tuberculosis</i> (Mtb) as well as a considerable inhibitory property against human angiotensin-converting enzyme (ACE) that plays a dynamic role in regulating blood pressure. The antireplicative effect of brassicasterol against HSV-1 is remarkably detected (50% inhibitory concentration (IC<sub>50</sub>): 1.2 µM; selectivity index (SI): 41.7), while the potency of its effect is ameliorated through the combination with standard acyclovir with proper SI (IC<sub>50</sub>: 0.7 µM; SI: 71.4). Moreover, the capacity of this compound to induce an adequate level of antituberculosis activity against all Mtb strains examined (minimum inhibitory concentration values ranging from 1.9 to 2.4 µM) is revealed. The anti-ACE effect (12.3 µg/mL; 91.2% inhibition) is also ascertained. Molecular docking analyses propose that the mechanisms by which brassicasterol induces anti-HSV-1 and anti-Mtb might be related to inhibiting vital enzymes involved in HSV-1 replication and Mtb cell wall biosynthesis. In summary, the obtained results suggest that brassicasterol might be promising for future anti-HSV-1, antituberculosis, and anti-ACE drug design.https://www.mdpi.com/2227-9059/8/5/132brassicasterolphytosterolsHSV<i>Mycobacterium tuberculosis</i>HSV-1 DNA polymeraseHSV-1 TK |
| spellingShingle | Sherif T. S. Hassan Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments Biomedicines brassicasterol phytosterols HSV <i>Mycobacterium tuberculosis</i> HSV-1 DNA polymerase HSV-1 TK |
| title | Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments |
| title_full | Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments |
| title_fullStr | Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments |
| title_full_unstemmed | Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments |
| title_short | Brassicasterol with Dual Anti-Infective Properties against HSV-1 and <i>Mycobacterium tuberculosis</i>, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments |
| title_sort | brassicasterol with dual anti infective properties against hsv 1 and i mycobacterium tuberculosis i and cardiovascular protective effect nonclinical in vitro and in silico assessments |
| topic | brassicasterol phytosterols HSV <i>Mycobacterium tuberculosis</i> HSV-1 DNA polymerase HSV-1 TK |
| url | https://www.mdpi.com/2227-9059/8/5/132 |
| work_keys_str_mv | AT sheriftshassan brassicasterolwithdualantiinfectivepropertiesagainsthsv1andimycobacteriumtuberculosisiandcardiovascularprotectiveeffectnonclinicalinvitroandinsilicoassessments |